The impact that this class of mutations can have on tumor biology is significant and is exemplified by the identification of a germline mutation in the CDKN2A tumor suppressor gene mapping 34 nucleotides upstream of the normal start site (Liu et al., 1999; Orlow et al., 2007). This evidence concerns the gene CDKN2A and neoplasm.